Under Armour-A Stock Forum

Good morning, traders. Happy Thursday, the market is trying to climb up after falling back. The Nasdaq and tech stocks were still in correction territory from their heights in the lush days of July. My name is Kevin Travers, here are moovin' stonks.
Eli Lilly $Eli Lilly and Co (LLY.US)$ posted a Q2 earnings beat, boosted by demand for the company's Mounjaro diabetes treatment and weight-loss drug Zepbound. The stock climbed 8%, and ...

Morning Movers
Gapping up
$Eli Lilly and Co (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$Apple (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...

$Eli Lilly and Co (LLY.US)$
The pharma giant will report quarterly numbers on Thursday morning.
Eli Lilly is up 32.5% so far in 2024.
The stock is 20% from the July high.
Eli Lilly is flat since over the past three months.
Retail earnings
$Under Armour-C (UA.US)$ $Under Armour-A (UAA.US)$ reports before the bell.
$Capri Holdings (CPRI.US)$ reports after the bell. Their brands include Versace, Jimmy Choo and Michael Kors.
$Under Armour-C (UA.US)$ are down ...

Since the beginning of this year, $Nike (NKE.US)$ and $Lululemon Athletica (LULU.US)$ have fallen by 32.7% and 43.7%, respectively, significantly underperforming the $Consumer Discretionary Select Sector Index (.SIXY.US)$, which has risen by 5.73%. However, companies such as $On Holding (ONON.US)$, $Deckers Outdoor (DECK.US)$, and $adidas AG (ADDYY.US)$ have performed well in the athletic apparel sector, with increases of 37.3%, 32.9%, ...